Related Experiment Videos
Impact of Continuous Pharmaceutical Care by a Collaborative Pharmacy Team on Reducing Drug-Related Problems in
Lingyan Gao1, Lina Zhang1, Zimeng Li1
1Department of Pharmacy, Aerospace Center Hospital, Beijing, China.
Aims:
Building upon continuous pharmaceutical care (CPC) models led solely by clinical pharmacists, this study evaluated a collaborative pharmacy team model for reducing drug-related problems (DRPs) in coronary heart disease (CHD) patients during care transitions.
Methods And Results:
In a randomized controlled trial, 60 hospitalized CHD patients were allocated equally to a CPC group or a usual-care control group. The CPC group received structured pharmaceutical interventions in which clinical pharmacists led hospital care and community pharmacists led post-discharge care during key care transition periods: within 24 hours of admission (T0), 24 hour pre-discharge (T1), 24-72 hour post-discharge (T2), and at 1-month follow-up (T3). DRPs were identified using the Pharmaceutical Care Network Europe (PCNE) classification. Mean DRPs per patient were comparable at T0 (Control: 3.03 ± 1.16 vs. CPC: 3.10 ± 1.24; p = 0.827). Subsequently, the CPC group showed significantly fewer DRPs than the control group at T1 (0.17 ± 0.59 vs. 2.13 ± 1.04), T2 (0.03 ± 0.18 vs. 1.97 ± 1.03), and T3 (0.67 ± 0.76 vs. 2.63 ± 1.13) (all p < 0.001). Pharmacist interventions in the CPC group had a high DRP acceptance rate 91.4% (181/198) and a resolution rate 89.1% (106/119). At 1-month follow-up, the CPC group demonstrated superior outcomes compared to the control group: LDL-C goal attainment (63.3% vs. 30.0%, p = 0.010), medication adherence (90.0% vs. 66.7%, p = 0.028), patient satisfaction (Numeric Rating Scale: 9.27 ± 0.52 vs. 8.59 ± 0.52, p < 0.001), and willingness to pay for pharmaceutical services (86.7% vs. 50.0%, p = 0.002).
Conclusion:
This collaborative pharmacy team model effectively reduced DRPs and improved lipid control and patient-reported outcomes in CHD patients, offering a scalable approach for integrated healthcare systems.Registered at the Chinese Clinical Trial Registry on July 1, 2024 (Registration number: ChiCTR2400086416; URL: https://www.chictr.org.cn/bin/project/edit?pid=235446).
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Nursing Clinical Information System
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
Oral Drug Delivery Systems: Continuous-Release Systems
Peripheral Artery Disease III: Interprofessional Care
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...